De Novo Hypoxemic Acute Respiratory Failure (hARF)

Clinical trial pipeline · Data from ClinicalTrials.gov

See which De Novo Hypoxemic Acute Respiratory Failure (hARF) trials you may qualify for

Total trials

Actively recruiting

Phase 3 trials

Completed

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

RecruitingNot Applicable

NCT06213168

Impact on Mortality of a Strategy Including Continuous Positive Airway Pressure Plus High Flow Nasal Cannula Oxygen Ther…

De novo hypoxemic acute respiratory failure (hARF) is one of the main causes of intensive care unit (ICU) admission. In de novo hARF, intubation is associated w…

France1,084 participantsStarted 2025-08-19

Treatment: HFNC, CPAP and HFNC

De Novo Hypoxemic Acute Respiratory Failure (hARF)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Impact on Mortality of a Strategy Including Continuous Positive Airway Pressure Plus High Flow Nasal Cannula Oxygen Ther…

All recent trials (1 shown)

Trial phase breakdown

Trial status

Actively recruiting — 1 trial

Impact on Mortality of a Strategy Including Continuous Positive Airway Pressure Plus High Flow Nasal Cannula Oxygen Ther…

All recent trials (1 shown)